Emerging infectious diseases: A proactive approach

Proceedings of the National Academy of Sciences of the United States of America

Volumn 114, Issue 16, 2017, Pages 4055-4059

  Bloom, David E ^a   Black, Steven ^b   Rappuoli, Rino ^c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c GSK   (Italy)

Author keywords

Ebola; Emerging infectious diseases; Human monoclonals; Vaccines; Zika

Indexed keywords

HUMAN MONOCLONAL ANTIBODY; VACCINE;

DENGUE; EBOLA HEMORRHAGIC FEVER; EPIDEMIC; ESCHERICHIA COLI O104:H4; FUNDING; GROSS NATIONAL PRODUCT; HERD IMMUNITY; HUMAN; INFECTION; INFLUENZA A (H1N1); INFLUENZA A (H5N1); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE EAST RESPIRATORY SYNDROME; NONHUMAN; PATENT; PRIORITY JOURNAL; PRIVATE SECTOR; RESOURCE ALLOCATION; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; WEST NILE FEVER; ZIKA FEVER; CLIMATE CHANGE; COMMUNICABLE DISEASE; GLOBAL HEALTH; IMMUNOLOGY; WORLD HEALTH ORGANIZATION;

CLIMATE CHANGE; COMMUNICABLE DISEASES, EMERGING; GLOBAL HEALTH; HUMANS; VACCINES; WORLD HEALTH ORGANIZATION;

EID: 85017665534     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1701410114     Document Type: Review

References (24)

1. Fauci AS, Morens DM (2012) The perpetual challenge of infectious diseases. N Engl J Med 366(5):454-461.
2. Acuna-Soto R, Stahle DW, Cleaveland MK, Therrell MD (2002) Megadrought and megadeath in 16th century Mexico. Emerg Infect Dis 8(4):360-362.
3. Potter CW (2001) A history of influenza. J Appl Microbiol 91(4):572-579.
4. State of the Tropics (2014) State of the Tropics 2014 report (James Cook Univ, Cairns, Australia).
5. Gallup JL, Sachs JD (2001) The economic burden of malaria. Am J Trop Med Hyg 64(1-2, Suppl):85-96.
6. Sachs J, Malaney P (2002) The economic and social burden of malaria. Nature 415(6872):680-685.
7. Keogh-Brown MR, Smith RD (2008) The economic impact of SARS: How does the reality match the predictions? Health Policy 88(1):110-120.
8. Bartsch SM, Gorham K, Lee BY (2015) The cost of an Ebola case. Pathog Glob Health 109(1):4-9.
9. Thomas MR, et al. (2015) The economic impact of Ebola on Sub-Saharan Africa: Updated estimates for 2015 (World Bank Group, Washington, DC).
10. Shepard DS, Coudeville L, Halasa YA, Zambrano B, Dayan GH (2011) Economic impact of dengue illness in the Americas. Am J Trop Med Hyg 84(2):200-207.
11. Burns A, van der Mensbrugghe D, Timmer H (2008) Evaluating the economic consequences of avian influenza. Report no. 47417 (World Bank Group, Washington, DC).
12. Jonas OB (2013) Pandemic risk (World Bank Group, Washington, DC).
13. Fan VY, Jamison DT, Summers LH (2016) The inclusive cost of pandemic influenza risk. NBER Working Paper no. 22137 (National Bureau of Economic Research, Cambridge, MA).
14. World Bank (2016) The short-term economic costs of Zika in Latin America and the Caribbean (LCR) (World Bank Group, Washington, DC). Available at pubdocs.worldbank.org/en/410321455758564708/The-short-term-economic-costs-of-Zika-in-LCR-final-doc-autores-feb-18.pdf.
15. Sands P, El Turabi A, Saynisch PA, Dzau VJ (2016) Assessment of economic vulnerability to infectious disease crises. Lancet 388(10058):2443-2448.
16. Ewer KJ, et al. (2016) Viral vectors as vaccine platforms: From immunogenicity to impact. Curr Opin Immunol 41:47-54.
17. Schwechheimer C, Kuehn MJ (2015) Outer-membrane vesicles from Gram-negative bacteria: Biogenesis and functions. Nat Rev Microbiol 13(10):605-619.
18. Scheid JF, et al. (2016) HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption. Nature 535(7613):556-572.
19. Plotkin SA, Mahmoud AAF, Farrar J (2015) Establishing a global vaccine-development fund. N Engl J Med 373(4):297-300.
20. Cohen J (September 2, 2016) New vaccine coalition aims to ward off epidemics. Science. Available at www.sciencemag.org/news/2016/09/new-vaccinecoalition-aims-ward-epidemics.
21. Rottingen J-A, et al. (2017) New vaccines against epidemic infectious diseases. N Engl J Med 376(7):610-613.
22. Cohen J (2017) A half-billion-dollar bid to head off emerging diseases. Science 355(6322):237.
23. World Health Organization (May 2016) An R&D blueprint for action to prevent epidemics. Available at apps.who.int/medicinedocs/documents/s22472en/s22472en.pdf.
24. Morens DM, Folkers GK, Fauci AS (2004) The challenge of emerging and re-emerging infectious diseases. Nature 430(6996):242-249.